Pharmion and Nippon Shinyaku Announce Licensing Agreement for Vidaza(R) in Japan (RedNova)
BOULDER, Colo., and KYOTO, Japan, Nov. 21 /PRNewswire-FirstCall/ -- Pharmion Corporation and Nippon Shinyaku Co., Ltd today announced the completion of an exclusive license agreement for development and commercialization rights to Vidaza (azacitidine for injectable suspension) in Japan.

FDA Lifts Silicone Breast Implant Ban (CBS News)
The government ended a 14-year virtual ban on silicone-gel breast implants despite lingering safety concerns over their safety. The move by the FDA mades the devices available to tens of thousands of women who have clamored for them.

Repligen Receives Orphan Drug Designation From the FDA for RG1068 for MRI Imaging of the Pancreas (RedNova)
WALTHAM, Mass., Nov. 21 /PRNewswire-FirstCall/ -- Repligen Corporation announced today that the Office of Orphan Products Development of the U.S.